FDA Issues Marketing Decisions on NJOY Ace E-Cigarette Products

Date:

On April 26, the FDA issued decisions on multiple NJOY Ace e-cigarette products, including the authorization of four new tobacco products through the Premarket Tobacco Product Application (PMTA) pathway.

The FDA issued marketing granted orders to NJOY LLC for its Ace closed e-cigarette device and three accompanying tobacco-flavored e-liquid pods, specifically:

  • NJOY Ace Device
  • NJOY Ace Pod Classic Tobacco 2.4%
  • NJOY Ace Pod Classic Tobacco 5%
  • NJOY Ace Pod Rich Tobacco 5%

This authorization allows these products to be legally marketed in the U.S. While this action permits these specific products to be sold in the U.S., it does not mean these products are safe nor are they “FDA approved.” All tobacco products are harmful and potentially addictive. Those who do not use tobacco products shouldn’t start.

The FDA also issued marketing denial orders to NJOY for multiple other Ace e-cigarette products. Any of those products currently on the market must be removed or FDA may take enforcement action. Retailers should contact NJOY with any questions about products in their inventory. Applications for two menthol-flavored Ace e-liquid pods remain under FDA review.

Read full article here.

U.S. Food and Drug Administration – 2022-04-26

Want More Investigative Content?

Curate RegWatch
Curate RegWatchhttps://regulatorwatch.com
In addition to our original coverage, RegWatch curates top stories on issues and impacts arising from the regulation of economic, social and environmental activity in Canada and the U.S.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

MORE VAPING

Harmful & Dangerous | YouTube Forces Label on Vape Content Creators...

Content creators on YouTube are being forced into a terrible choice either self-mark pro-vaping content as “harmful & dangerous” or face a litany of...

Vaping Coverage Get it NOW!

Sign Up for Incisive Content!

RegWatch original video is designed to move opinion. Get our videos first and be the first to share.

Your Information will never be shared with any third party